Phase I Study of Difluoromethylornithine in Combination with Recombinant α2a-Interferon

John H. Edmonson; John S. Kovach; Jan C. Buckner; Larry K. Kvols; Richard G. Hahn

AACR Publications

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

AACR Publications

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

Clinical and Epidemiological Investigations

Phase I Study of Difluoromethylornithine in Combination with Recombinant α2a-Interferon

John H. Edmonson, John S. Kovach, Jan C. Buckner, Larry K. Kvols and Richard G. Hahn

John H. Edmonson

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John S. Kovach

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jan C. Buckner

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Larry K. Kvols

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Richard G. Hahn

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: Published November 1988

Article
Info & Metrics
PDF

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: February 2001 to January 2021

	Abstract	Full-text HTML	PDF
Total	444	2	305

Cited By

Article Information

Volume 48, Issue 22, pp. 6584-6586

PubMed

3141046

Published By

American Association for Cancer Research

Print ISSN

0008-5472

Online ISSN

1538-7445

History

Received March 28, 1988
Revision received August 3, 1988
Accepted August 9, 1988
Published first November 1, 1988.

Author Information

John H. Edmonson²,
John S. Kovach,
Jan C. Buckner,
Larry K. Kvols, and
Richard G. Hahn

Mayo Clinic, Rochester, Minnesota 55905

PreviousNext

November 1988
Volume 48, Issue 22

Table of Contents
Table of Contents (PDF)
Back Matter (PDF)
Editorial Board (PDF)
Front Matter (PDF)

Search for this keyword

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Phase I Study of Difluoromethylornithine in Combination with Recombinant α2a-Interferon

Message Subject (Your Name) has forwarded a page to you from Cancer Research

Message Body (Your Name) thought you would be interested in this article in Cancer Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Phase I Study of Difluoromethylornithine in Combination with Recombinant α2a-Interferon

John H. Edmonson, John S. Kovach, Jan C. Buckner, Larry K. Kvols and Richard G. Hahn

Cancer Res November 15 1988 (48) (22) 6584-6586;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Phase I Study of Difluoromethylornithine in Combination with Recombinant α2a-Interferon

John H. Edmonson, John S. Kovach, Jan C. Buckner, Larry K. Kvols and Richard G. Hahn

Cancer Res November 15 1988 (48) (22) 6584-6586;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics
PDF

Cited By...

Clinical and Epidemiological Investigations

Association between Hepatitis C Virus Antibodies and Hepatocellular Carcinoma in Taiwan
Evaluation of Nontumorous Tissue Damage by Transcatheter Arterial Embolization for Hepatocellular Carcinoma
Comparison of Immunoscintigraphy and Computerized Tomography in Identifying Colorectal Cancer: Individual Lesion Analysis

Show more Clinical and Epidemiological Investigations

Articles

Association between Hepatitis C Virus Antibodies and Hepatocellular Carcinoma in Taiwan
Evaluation of Nontumorous Tissue Damage by Transcatheter Arterial Embolization for Hepatocellular Carcinoma
Comparison of Immunoscintigraphy and Computerized Tomography in Identifying Colorectal Cancer: Individual Lesion Analysis

Show more Articles

Home
Alerts
Feedback
Privacy Policy

Articles

Online First
Current Issue
Past Issues
Meeting Abstracts

Info for

Authors
Subscribers
Advertisers
Librarians

About Cancer Research

About the Journal
Editorial Board
Permissions
Submit a Manuscript

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Main menu

User menu

Search

Phase I Study of Difluoromethylornithine in Combination with Recombinant α2a-Interferon

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: February 2001 to January 2021

Cited By

Article Information

Author Information

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Clinical and Epidemiological Investigations

Articles

Articles

Info for

About Cancer Research